A plan to give people in the u.s. Easier access to unproven drugs was opposed by most fda staff members. The effort on peptides was driven almost entirely by HHS.
Peptides are deemed safe for use by specialty businesses that make customized medications. The agency's scientific staffers have major safety concerns. Decisions over compounding have long rested with the FDA.
Federal law gives HHS authority over all drug regulations. Peptide sellers often try to skirt US regulation by labeling their products as "for research use only"
This summary was written with AI assistance from the original article and may leave out important context. The original reporting belongs to The Guardian · Health. Check the original, and official sources, before acting on any detail.